Last Updated: August 18, 2025
Your definitive resource for Studio LSD IPO analysis, live GMP updates, financials, risks, and expert insights.
Live Grey Market Premium (GMP) Update
- Studio LSD IPO GMP Today: ₹15 – ₹17
- Expected Listing Price Range: ₹66 – ₹71 per share
- GMP Trend (Last 3 Days): Steady/Increasing
- Indicative Listing Gain: 22% – 31% (Based on upper price band of ₹54)
Note: GMP fluctuates daily. Check our LIVE IPO GMP Tracker for real-time updates.
About Studio LSD IPO: Key Details at a Glance
| Parameter | Details |
|---|---|
| IPO Open Date | August 18, 2025 |
| IPO Close Date | August 20, 2025 |
| Price Band | ₹51 – ₹54 per share |
| Face Value | ₹10 per share |
| Lot Size | 2,000 Shares |
| Min Retail Investment | ₹108,000 (2 lots) |
| Total Issue Size | ₹74.25 Crores (1.38 Cr shares) |
| Fresh Issue | ₹59.40 Cr (1.10 Cr shares) |
| Offer for Sale (OFS) | ₹14.85 Cr (0.28 Cr shares by promoters) |
| Listing Exchange | NSE SME |
| Tentative Listing | August 25, 2025 |
About Studio LSD Ltd.: Creative Powerhouse
Studio LSD Limited (founded Feb 2017) is a Mumbai-based multimedia production house creating original content for TV and OTT platforms. Known for innovative storytelling like “Chronicles of Aghori” and “Mumbai Diaries 2099,” the company handles end-to-end production:
- Concept Development & Scriptwriting
- Line Production & Location Scouting
- Post-Production & VFX
- Distribution & Marketing
Competitive Strengths:
- Experienced Leadership: Founders with 15+ years in media.
- High-Quality Portfolio: 12+ critically acclaimed series.
- Scalable Model: Partnerships with Netflix, Disney+ Hotstar, SonyLiv.
- Asset-Light Operations: Low debt and high margins.
IPO GMP Analysis & Listing Gain Potential
- Current GMP: ₹15 – ₹17 (as of August 16, 2025)
- Kostak Rate: ₹8,500 per lot (fee for confirmed allotment).
- Subject-to-Saar (SS) Rate: ₹14 (premium per share without allotment guarantee).
Listing Gain Forecast:
| Scenario | Listing Price | Gain (%) | Profit per Lot (2,000 shares) |
|---|---|---|---|
| Conservative | ₹66 | 22.2% | ₹24,000 |
| Optimistic | ₹71 | 31.5% | ₹34,000 |
Factors Driving Demand: Strong content pipeline, OTT industry growth (18% CAGR), and low debt.
Financial Performance: Year-Wise Breakdown (₹ Crores)
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | 2-Yr CAGR |
|---|---|---|---|---|
| Total Revenue | 105.01 | 102.49 | 46.71 | 50.1% |
| Net Profit | 11.67 | 10.90 | 2.79 | 104.3% |
| EBITDA | 15.51 | 14.82 | 3.74 | 103.5% |
| Total Assets | 46.67 | 36.49 | 18.16 | 60.3% |
| Net Worth | 27.54 | 15.87 | 4.96 | 132.8% |
| Debt | 0.00 | 0.00 | 0.06 | N/A |
Key Takeaways:
- Revenue growth stabilized in FY25, but profitability surged.
- Zero debt since FY24 enhances financial flexibility.
- ROE improved to 53.78% (FY25) from 36.2% (FY23).
IPO Application & Lot Size Details
- Min Application: 1 lot (2,000 shares) = ₹108,000
- Max Retail Application: 2 lots (4,000 shares) = ₹216,000
- HNI (S-HNI): 3-9 lots (6,000-18,000 shares) = ₹324,000 – ₹972,000
- HNI (B-HNI): 10+ lots (20,000+ shares) = ₹1,080,000+
How to Apply:
- Via ASBA (Net Banking): Log in to bank portal → IPO section → Bid using UPI.
- Via Broker (Zerodha/Upstox): Go to Console → IPOs → Select Studio LSD → Place bid.
Reservation Quota & Promoter Holding
Share Allocation:
| Investor Category | Shares Reserved | % of Offer | Amount (₹ Cr) |
|---|---|---|---|
| Market Maker | 688,000 | 5.00% | ₹3.72 |
| QIB | 132,000 | 0.96% | ₹0.71 |
| NII (HNI) | 5,172,000 | 37.61% | ₹27.92 |
| Retail | 7,758,000 | 56.42% | ₹41.89 |
| Total | 13,750,000 | 100.00% | ₹74.25 |
Promoter Holding Change:
- Pre-IPO: 100% (40.89 million shares)
- Post-IPO: 73.5% (dilution due to fresh issue).
Objectives of the Issue
Proceeds will be used for:
- Capital Expenditure (₹18 Cr): Upgrading editing studios and VFX infrastructure.
- Working Capital (₹24.92 Cr): Funding 3 new web series and a feature film.
- General Corporate Purposes (Balance): Operational expenses and market expansion.
IPO Timeline: Critical Dates
| Event | Date | Day |
|---|---|---|
| IPO Opens | August 18, 2025 | Monday |
| IPO Closes | August 20, 2025 | Wednesday |
| Allotment Finalized | August 21, 2025 | Thursday |
| Refund Initiation | August 22, 2025 | Friday |
| Shares Credited | August 22, 2025 | Friday |
| Listing Date | August 25, 2025 | Monday |
Investment Limits:
- Retail: Up to ₹216,000
- HNI: ₹324,000+
- QIB: No upper limit
Key Performance Indicators (KPIs)
| Metric | Pre-IPO | Post-IPO | Industry Avg. |
|---|---|---|---|
| ROE (%) | 53.78 | 42.10 | 25.3 |
| ROCE (%) | 57.29 | 48.50 | 28.6 |
| PAT Margin (%) | 11.17 | 9.25 | 8.2 |
| EBITDA Margin (%) | 14.85 | 13.10 | 12.0 |
| EPS (₹) | 2.85 | 2.25 | – |
| P/E (x) | 18.92 | 24.01 | 32.4 |
| Book Value (₹) | 6.74 | 10.62 | – |
Post-IPO P/E is still below industry average, indicating room for growth.
Risk Factors
- Content Flop Risk: Failure of new shows impacts revenue.
- Platform Dependency: 65% revenue tied to 2 OTT partners.
- Regulatory Changes: Stricter content laws could delay releases.
- Talent Retention: High competition for skilled directors/writers.
- Working Capital Cycles: Production delays strain liquidity.
Company & Registrar Contact
Studio LSD Ltd.
Unit 302-301, 3rd Floor, Laxmi Mall,
Laxmi Industrial Estate, New Link Road,
Andheri West, Mumbai – 400053
📞 +91 91371 95384
✉️ compliance@studiolsd.in
🌐 https://www.studiolsd.in/
Registrar: Purva Sharegistry (India) Pvt. Ltd.
📞 +91-022-23018261
✉️ newissue@purvashare.com
🌐 https://www.purvashare.com
IPO Recommendation: Subscribe for Listing Gains
Pros:
✅ High GMP indicates strong listing pop (20-30%).
✅ Debt-free balance sheet with improving margins.
✅ Experienced promoters with skin in the game (73.5% post-IPO).
✅ Undervalued vs. peers (post-P/E of 24x vs industry 32x).
Cons:
❌ Small issue size may lead to oversubscription frenzy.
❌ Limited operating history (only 8 years).
❌ Concentrated revenue streams.
Verdict:
- Short-Term: SUBSCRIBE for likely listing gains.
- Long-Term: Wait for 2 quarters post-listing to evaluate content pipeline execution.
Allotment & Refunds Process
- Allotment Status: Check via BSE/NSE website or registrar portal (Aug 21).
- Refund Timeline: By Aug 22 if not allotted.
- Payment Methods: UPI/ASBA refunds processed automatically.
- Post-Allotment Action:
- Hold if: Bullish on OTT growth and Studio LSD’s IP pipeline.
- Sell on Listing if: Targeting quick gains (recommended for retail).
RHP/DRHP: Must-Read Documents
- Studio LSD DRHP: Download Document
- Studio LSD RHP: Download Document
Studio LSD IPO Review: Balanced Perspective
Opportunities:
- India’s OTT market to hit $12.5Bn by 2028 (FICCI).
- Global demand for regional language content rising.
- Asset-light model allows high scalability.
Threats:
- Intense competition from established players (Dharma, Red Chillies).
- Rising production costs squeezing margins.
Studio LSD IPO FAQs (10 Key Questions)
1. What is Studio LSD IPO GMP today?
→ ₹15-₹17 (indicating a likely ₹66-₹71 listing price).
2. How to apply for Studio LSD IPO via Zerodha?
→ Login → Console → IPOs → Select “Studio LSD” → Bid via UPI.
3. What is the lot size?
→ 2,000 shares. Min investment: ₹108,000.
4. When will allotment happen?
→ August 21, 2025.
5. What is the listing date?
→ Tentatively August 25, 2025, on NSE SME.
6. Who are the promoters?
→ Mr. Prateek Sharma, Mrs. Suman Sharma, Mr. Parth Shah.
7. What is the post-IPO promoter holding?
→ 73.5% (down from 100%).
8. Why is the IPO raising funds?
→ Capex (₹18 Cr), working capital (₹24.92 Cr), and corporate needs.
9. Is Studio LSD profitable?
→ Yes, ₹11.67 Cr PAT in FY25 (up 7% YoY).
10. Should I invest long-term?
→ Only if bullish on content IP scalability; else book listing gains.
